Zeynep Eroglu, MD

Trials

Studies that name Zeynep Eroglu, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:36 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07930182 · Adjuvant/Neoadjuvant Immunotherapy in Melanoma Based on Serial Plasma ctDNA Monitoring

  H. Lee Moffitt Cancer Center and Research Institute · recruiting · Melanoma · principal investigator
• Early Ph1
  NCT05651828 · Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma

  H. Lee Moffitt Cancer Center and Research Institute · recruiting · Advanced Basal Cell Carcinoma · principal investigator
• Ph2
  NCT05070403 · Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma

  H. Lee Moffitt Cancer Center and Research Institute · active not recruiting · Squamous Cell Carcinoma · principal investigator
• Ph2
  NCT04996823 · Axitinib + Ipilimumab in Advanced Melanoma

  H. Lee Moffitt Cancer Center and Research Institute · active not recruiting · Melanoma · principal investigator
• Early Ph1
  NCT04741997 · Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma

  H. Lee Moffitt Cancer Center and Research Institute · recruiting · Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 00:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.